Clinical Outcome of Hypertrophic Cardiomyopathy in Probands with the Founder Variant c.913_914del in MYBPC3: A Slovenian Cohort Study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Clinical Outcome of Hypertrophic Cardiomyopathy in Probands with the Founder Variant c.913_914del in MYBPC3: A Slovenian Cohort Study ; day:19 ; month:8 ; year:2024 ; pages:1-11
Journal of cardiovascular translational research ; (19.8.2024), 1-11
- Creator
-
Vodnjov, Nina
Maver, Aleš
Teran, Nataša
Peterlin, Borut
Toplišek, Janez
Writzl, Karin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12265-024-10551-5
- URN
-
urn:nbn:de:101:1-2411052129020.993199464348
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vodnjov, Nina
- Maver, Aleš
- Teran, Nataša
- Peterlin, Borut
- Toplišek, Janez
- Writzl, Karin
- SpringerLink (Online service)
Other Objects (12)
MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onset
Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers
Pediatric hypertrophic cardiomyopathy caused by a novel TNNI3 variant
Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants
Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy
Hypertrophic Cardiomyopathy with a Twist
Diagnosis and management of hypertrophic cardiomyopathy
Regional myocardial function at preclinical disease stage of hypertrophic cardiomyopathy in female gene variant carriers
Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy
Non-contrast T1rho CMR for hypertrophic cardiomyopathy
Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy
Molecular mechanisms of RASopathy-associated hypertrophic cardiomyopathy
MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onset
Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers
Pediatric hypertrophic cardiomyopathy caused by a novel TNNI3 variant
Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants
Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy
Hypertrophic Cardiomyopathy with a Twist
Diagnosis and management of hypertrophic cardiomyopathy
Regional myocardial function at preclinical disease stage of hypertrophic cardiomyopathy in female gene variant carriers
Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy
Non-contrast T1rho CMR for hypertrophic cardiomyopathy
Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy
Molecular mechanisms of RASopathy-associated hypertrophic cardiomyopathy
MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onset
Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers
Pediatric hypertrophic cardiomyopathy caused by a novel TNNI3 variant
Improving risk prediction in hypertrophic cardiomyopathy: the key role of Dutch founder variants
Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy
Hypertrophic Cardiomyopathy with a Twist
Diagnosis and management of hypertrophic cardiomyopathy
Regional myocardial function at preclinical disease stage of hypertrophic cardiomyopathy in female gene variant carriers
Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy
Non-contrast T1rho CMR for hypertrophic cardiomyopathy
Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy